Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FF 705

Known as: FF-705 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
alpha-Difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, reduced intestinal lesions in tumor-bearing mice… Expand
Is this relevant?
1988
1988
  • Hidetoshi Fujita
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1988
  • Corpus ID: 26250107
5-FU is metabolized to FUTP and FdUMP in tumor cells and exhibits RNA- and DNA-directed cytotoxicity. Biochemical modulation of… Expand
Is this relevant?
1984
1984
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1984
  • Corpus ID: 28230969
Clinical efficacy of new fluorouridine derivative, FF-705, was studied in 108 patients with advanced malignant tumors. Partial… Expand
Is this relevant?
1984
1984
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1984
  • Corpus ID: 24670351
A phase I study of a new floxuridine derivative, FF-705, was performed in patients with various types of solid tumors. Efficacy… Expand
Is this relevant?
1984
1984
  • Hirotaka Fujita
  • Gan to kagaku ryoho. Cancer & chemotherapy
  • 1984
  • Corpus ID: 20673552
Many derivatives modifying chemical structures have been synthesized from several drugs. These include following antibiotics… Expand
Is this relevant?